Psoriasis - Immunopathology and immunomodulation

被引:32
作者
Gottlieb, AB [1 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Clin Res Ctr, New Brunswick, NJ 08901 USA
关键词
D O I
10.1016/S0733-8635(05)70306-5
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Biologics in development for the treatment of moderate to severe plaque-type psoriasis are discussed in this article. Immunomodulators used as therapeutic, pathogenic probes will continue to identify targets that play primary roles in the pathogenesis of psoriasis.
引用
收藏
页码:649 / +
页数:10
相关论文
共 66 条
[1]   Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells [J].
Abrams, JR ;
Kelley, SL ;
Hayes, E ;
Kikuchi, T ;
Brown, MJ ;
Kang, SW ;
Lebwohl, MG ;
Guzzo, CA ;
Jegasothy, BV ;
Linsley, PS ;
Krueger, JG .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (05) :681-693
[2]   IL-10 is a key cytokine in psoriasis -: Proof of principle by IL-10 therapy:: A new therapeutic approach [J].
Asadullah, K ;
Sterry, W ;
Stephanek, K ;
Jasulaitis, D ;
Leupold, M ;
Audring, H ;
Volk, HD ;
Döcke, WD .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :783-794
[3]   PUVA THERAPY DECREASES HLA-DR+ CDIA+ LANGERHANS CELLS AND EPIDERMAL-CELL ANTIGEN-PRESENTING CAPACITY IN HUMAN-SKIN, BUT FLOW CYTOMETRICALLY-SORTED RESIDUAL HLA-DR+ CDIA+ LANGERHANS CELLS EXHIBIT NORMAL ALLOANTIGEN-PRESENTING FUNCTION [J].
ASHWORTH, J ;
KAHAN, MC ;
BREATHNACH, SM .
BRITISH JOURNAL OF DERMATOLOGY, 1989, 120 (03) :329-339
[4]  
Austin L, 1998, J INVEST DERMATOL, V110, P649
[5]   Intraepidermal lymphocytes in psoriatic lesions are activated GMP-17(TIA-1)+CD8+CD3+CTLs as determined by phenotypic analysis [J].
Austin, LM ;
Coven, TR ;
Bhardwaj, N ;
Steinman, R ;
Krueger, JG .
JOURNAL OF CUTANEOUS PATHOLOGY, 1998, 25 (02) :79-88
[6]   The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations:: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients [J].
Austin, LM ;
Ozawa, M ;
Kikuchi, T ;
Walters, IB ;
Krueger, JG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (05) :752-759
[7]  
BAKER BS, 1985, CLIN EXP IMMUNOL, V61, P526
[8]   THE IMMUNOLOGY OF PSORIASIS [J].
BAKER, BS ;
FRY, L .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 (01) :1-9
[9]  
BAKER BS, 1984, BRIT J DERMATOL, V110, P555
[10]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071